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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The primary objective of this review is to determine the effects of therapeutic exercises on oral swallowing, aspiration and adverse
events, in people treated curatively for an advanced-stage (stage III, stage IV) squamous cell carcinoma of the head and neck.
B A C K G R O U N D
Description of the condition
Cancers that are known collectively as ’head and neck cancers’
include squamous cell carcinomas of the head and neck. Over
80% originate in the squamous cells that line the moist, mucosal
surfaces of the head and neck (inside the mouth, the nose and the
throat).
Head and neck cancers are a heterogeneous group, consisting of
cancers of the mouth (base of tongue, other tongue, gum, floor of
mouth, palate and other mouth), salivary glands, pharynx (ton-
sil, oropharynx, nasopharynx, pyriform fossa, hypopharynx, other
mouth/pharynx), nasal cavity,middle ear, sinuses and larynx.Over
the past decade, there has been a rise in the incidence of oropha-
ryngeal squamous cell cancer (specifically of the lingual and pala-
tine tonsils) in white men, younger than 50 years of age, who have
no recorded history of alcohol or tobacco use; this is associated
with human papillomavirus (HPV) infection rather than tobacco
and alcohol usage (Marur 2010; Ragin 2007).
Overall, head and neck cancer accounts for more than 550,000
cases annually worldwide. Males are affected significantly more
than females with a ratio ranging from 2:1 to 4:1. The incidence
rate in males exceeds 20 per 100,000 in regions of France, Hong
Kong, the Indian subcontinent, central and eastern Europe, Spain,
Italy, Brazil and among African Americans in the Unites States.
Mouth and tongue cancers are more common in the Indian sub-
continent, nasopharyngeal cancer ismore common inHongKong,
and pharyngeal and/or laryngeal cancers are more common in
other populations (Jemal 2011).
Although the incidence is relatively low, survival remains poor as
people (who are mainly men) often present late to treatment. Five-
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year relative survival from head and neck cancer in Europe ranges
from 20% in Slovakia to 51% in the Netherlands, with the figure
for Ireland (37%) being close to the average (www.ncri.ie).
Most head and neck cancers develop in the upper aerodigestive
epithelium after exposure to carcinogens such as tobacco and alco-
hol, although human papillomavirus (HPV) has also been strongly
implicated as a causative agent in a subset of these cancers (Argiris
2008). The goals of treatment are to improve survival outcomes
but also to preserve organ form/function.
Treatments for advanced head and neck cancer include: surgery
and radiation therapy; surgery and chemoradiotherapy; or
chemoradiotherapy without surgery. The benefits of concurrent
chemotherapy and radiation therapy on survival were confirmed
by Pignon et al in 2009 in a meta-analysis of 84 trials (Pignon
2009). However, such improvements have resulted in an increased
prevalence of dysphagia (difficulty in swallowing) in survivors.
Description of the problem
Although survival rates from head and neck cancer have improved
overall, this has been due to more aggressive treatment so morbid-
ity has correspondingly increased. Morbidity includes dysphagia,
which may be due to the cancer itself or may occur as a result of
modern aggressive treatment(s), or both. Dysphagia ranges from
a temporary problem in swallowing (due to mucositis or xerosto-
mia during treatment) through to a more long-term or even per-
manent problem (due to fibrosis or a stricture), which results in
non-oral tube feeding being needed, using a nasogastric tube or a
percutaneous endoscopic gastrostomy.
The consequences of dysphagia are not only a reduction of food/
fluid intake, but often a reduction in people’s activity and social
participation (ICF 2001), with corresponding negative changes to
their quality of life. In countries where much socialisation revolves
around preparing and eating food together, psychological well-
being can be negatively affected by dysphagia (Rappoport 2003).
Description of the intervention
Dysphagia therapy is recognised internationally as the provision
of services to patients with a difficulty in swallowing, usually by
a speech and language therapist (also known as a speech pathol-
ogist or speech therapist). Therapy may occur through using be-
havioural management procedures, principally divided into com-
pensatory strategies and direct techniques (Logemann 1999). Di-
rect techniques are the focus of this review.
Direct techniques (also known as therapeutic exercises) consist of
either swallowing or neuromuscular exercises. Swallowing exercises
are designed to change the swallow physiology by improving sen-
sory motor integration or by gaining voluntary control over the
timing or the co-ordination of selected oropharyngeal movements
during swallowing (Logemann 1999).
Neuromuscular exercises target tongue strength, endurance and/
or power. Strength is achieved by exercises that use high levels
of resistance (isometric) exercises. Endurance is achieved through
repeated performance of exercises involving low levels of resistance.
Power is achieved by using exercises that focus on the speed of
muscle contraction (Clark 2003).
How the intervention might work
Swallowing exercises are designed to improve swallowing safety (i.e.
to reduce penetration, in which a bolus (a ball of food, fluid) en-
ters the larynx at/above the vocal folds, or to reduce aspiration, in
which a bolus enters below the vocal folds into the trachea/upper
airway). Other swallowing exercises are designed to improve effi-
ciency (i.e. to increase the speed or amount of a bolus swallowed,
or both) (Logemann 1999).
Neuromuscular exercises are designed to increase tongue range of
motion and/or strength, thus indirectly improving oral bolus tran-
sit (speed and bolus clearance) as tongue force/strength is a key
component of a safe swallow. Exercises to increase tongue range
of motion are used to keep the tongue mobile during/after head
and neck cancer treatment and to mitigate against the stiffening
and fibrosis that can result from radiotherapy and/or from surgery
(Appleton 1994).
Why it is important to do this review
Changes to head and neck cancer treatment mean that patient
survival has improved over the last decade, but this has been at the
expense of increased morbidity (speech, swallowing function).
Treatment nowadays promotes ’organ preservation’, which is ap-
pealing, but preservation of structure does not alwaysmean preser-
vation of function and, unfortunately, some head and neck can-
cer treatment regimens have profound and long-lasting negative
side effects. Indeed, all head and neck cancer treatments have side
effects, but these are compounded when multi-modal treatments
are used, as in modern protocols.
A swallowing problem (dysphagia) is now widely accepted as both
an acute and a late toxicity after radiotherapy treatment and it
has been stated that, “the problem of swallowing dysfunction is
probably becoming one of the most important and clinically rel-
evant side effects after curative radiotherapy or chemo-radiation.”
(Langendijk 2007).
Given the need to prevent and/or reduce treatment-related mor-
bidity in order to reduce the survivorship burden for patients
and families, as well as the cost to healthcare systems, a review
of the usefulness of therapeutic exercises for affecting post-treat-
ment swallowing in patients treated for advanced squamous cell
carcinoma of the head and neck using Cochrane methodology is
warranted.
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O B J E C T I V E S
The primary objective of this review is to determine the effects
of therapeutic exercises on oral swallowing, aspiration and adverse
events, in people treated curatively for an advanced-stage (stage
III, stage IV) squamous cell carcinoma of the head and neck.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will only include blinded and unblinded randomised con-
trolled trials (RCTs) of patients with advanced (stage III, stage IV)
head and neck cancer.
Types of participants
Adults who are treated with surgery and radiation therapy, surgery
and chemoradiotherapy, or chemoradiotherapy without surgery
for large (stage III, stage IV) squamous cell carcinoma of the head
and neck, who are at risk of, or are presenting with, dysphagia
(swallowing impairment). We will include people at all levels of
dysphagia severity and will set no age limits.
We will look separately at patients presenting with dysphagia and
at patients receiving interventions designed to prevent swallowing
problems when they undergo cancer treatment.
Types of interventions
Wewill include direct therapeutic techniques involving swallowing
and/or neuromuscular exercises.
Therapy programmes may be delivered pre- peri- or post-head
and neck cancer treatment, but they must last for more than one
session. Interventions may be provided by one or more health
disciplines (for example, we will include studies involving only
speech and language therapists).
Types of outcome measures
Primary outcomes
• Safety and efficiency of oral swallowing, as measured by:
◦ reduced/no aspiration;
◦ adverse events, such as chest infections, aspiration
pneumonia, profound weight loss;
◦ oropharyngeal swallowing efficiency (OPSE)
measures, taken from videofluoroscopy swallowing studies.
Secondary outcomes
• Time to return to function (swallowing).
• Self reported changes to quality of life.
• Changes to psychological well-being: depression, anxiety
and stress (DAS).
• Patient satisfaction with the intervention.
• Patient compliance with the intervention.
• Cost-effectiveness of the intervention.
Search methods for identification of studies
We will conduct systematic searches for randomised controlled
trials. There will be no language, publication year or publication
status restrictions.Wemay contact original authors for clarification
and further data if trial reports are unclear and we will arrange
translations of papers where necessary.
Electronic searches
We will identify published, unpublished and ongoing studies
by searching the following databases from their inception: the
Cochrane Ear, Nose and Throat Disorders Group Trials Register;
the Cochrane Central Register of Controlled Trials (CENTRAL,
current issue); Ovid MEDLINE; Ovid MEDLINE In-Process &
Other Non-Indexed Citations; PubMed (as a top up to searches
in OvidMEDLINE); EMBASE; CINAHL; LILACS; KoreaMed;
IndMed; PakMediNet; CAB Abstracts; Web of Science; ISRCTN;
ClinicalTrials.gov; ICTRP; speechBITE (Australian speech and
language therapy database); Google Scholar and Google.
Wewillmodel subject strategies for databases on the search strategy
designed for CENTRAL (Appendix 1).
Searching other resources
We will scan the reference lists of identified publications for addi-
tional trials and contact trial authors if necessary. We will search
dissertation abstracts and contact key researchers in the area and
international head and neck cancer organisations to request infor-
mation about any unpublished or ongoing studies. In addition,
we will search PubMed, TRIPdatabase, The Cochrane Library and
Google to retrieve existing systematic reviews relevant to this sys-
tematic review, so that we can scan their reference lists for ad-
ditional trials. We will search for conference abstracts using the
Cochrane Ear, Nose and Throat Disorders Group Trials Register
and EMBASE.
Data collection and analysis
Selection of studies
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Two review authors (AP and SC) will independently review the
titles and abstracts of the records identified fromelectronic searches
and exclude immediately irrelevant studies. We will obtain the full
text of the remaining studies and two review authors (AP and CK)
will select studies based on the inclusion criteria of the review. If
these authors are unsure, then the third review author (SC) will
make a final decision. We will contact trial authors for further
details when required.Wewill document the reasons for exclusion.
Data extraction and management
Two review authors (AP and CK) will independently extract study
data and record information on a data extraction form. We will
resolve discrepancies through discussion. We will extract the fol-
lowing from each study:
1. Citation details: title, authors, source and year of
publication.
2. Participant inclusion and exclusion criteria.
3. Participant details: age, gender, location/size of tumour,
time since diagnosis, level of swallowing ability, setting.
4. Recruitment details: number of people screened, eligible,
recruited and randomised, withdrawals.
5. Methodological quality details (by use of The Cochrane
Collaboration’s tool for assessing risk of bias).
6. Intervention details: description of intervention/exercises,
personnel involved, training of personnel, duration, dosage,
comparison intervention.
7. Outcome measures: measures chosen, by whom and when
they were administered, how they were administered (in person,
via other communication technologies or by mail).
8. Study results (positive, negative, equivocal results,
withdrawal).
Where required, we will contact trial authors for missing informa-
tion. We will resolve differences by discussion or by referral to a
third review author, if needed.
Assessment of risk of bias in included studies
Two review authors (AP and CK) will undertake assessment of the
risk of bias of the included trials independently, with the following
taken into consideration, as guided by theCochrane Handbook for
Systematic Reviews of Interventions (Handbook 2011):
• sequence generation;
• allocation concealment;
• blinding;
• incomplete outcome data;
• selective outcome reporting; and
• other sources of bias.
We will use the Cochrane ’Risk of bias’ tool in RevMan 5.2 (
RevMan 2012), which involves describing each of these domains
as reported in the trial and then assigning a judgement about the
adequacy of each entry as: ’low’, ’high’ or ’unclear’ risk of bias.
Measures of treatment effect
Two review authors (AP and CK) will independently assign out-
come measures to the domain assessed (oral swallowing; aspira-
tion; adverse events; time to return to oral swallowing; quality of
life; psychological well-being; patient satisfaction; patient compli-
ance; cost-effectiveness of intervention).
If more than one outcome measure is used for the same domain
from the same study, we will include the measure most frequently
used across included studies.
If possible, we will conduct separate analyses for short-term (three
months or less) and long-term (more than three months) out-
comes.
We will calculate risk ratios (RR) and 95% confidence intervals
(CI) for dichotomous outcomes and mean differences (MD) or
standardised mean differences (SMD) and 95%CI for continuous
outcomes, as appropriate.
Unit of analysis issues
The unit of randomisation in these trials will be the individual
patient.
Dealing with missing data
We will contact trial authors for missing data. We will convert
available data where possible (for example, when data are reported
as standard error) using the procedures detailed in the Cochrane
Handbook for Systematic Reviews of Interventions (Handbook
2011). Where possible, as recommended in the Cochrane Hand-
book for Systematic Reviews of Interventions, we will conduct inten-
tion-to-treat analyses. Where drop-outs are clearly identified, we
will use the denominator of participants contributing data at the
relevant outcome assessment.
Assessment of heterogeneity
We will pool results to present an overall estimate of the treatment
effect, using a random-effects model. We will assess heterogeneity
by visual inspection of the forest plot along with consideration
of the Chi2 test for heterogeneity and the I2 statistic (Handbook
2011).
Data synthesis
We will conduct a meta-analysis using a random-effects model
with 95% CI using RevMan 5.2 (RevMan 2012). We will explore
heterogeneity as detailed above.
Subgroup analysis and investigation of heterogeneity
If there are sufficient number of comparable studies (four ormore),
wewill perform subgroup analyses to determinewhether outcomes
vary according to:
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• type of therapeutic exercise (swallowing and/or
neuromuscular);
• when therapeutic exercises were initiated (pre-, peri- or
post-cancer treatment);
• frequency of therapeutic exercise;
• intensity of therapeutic exercise (dosage - number of hours
of intervention);
• intervention approach (for example, retraining with a
speech and language therapist or self directed);
• mode of delivery (face to face versus use of a brochure/
DVD);
• whether the intervention is provided by a healthcare
professional or not;
• cancer treatment modality (surgery and radiation therapy;
surgery and chemoradiotherapy; chemoradiotherapy treatment
without surgery);
• site of tumour;
• size of tumour;
• HPV status.
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Oropharyngeal Neoplasms] explode all trees
#2 MeSH descriptor: [Head and Neck Neoplasms] this term only
#3 MeSH descriptor: [Pharyngeal Neoplasms] this term only
#4 MeSH descriptor: [Otorhinolaryngologic Neoplasms] this term only
#5 MeSH descriptor: [Neoplasms] explode all trees
#6 cancer* or carcinoma* or neoplas* or tumor* or tumour* or malignan* or SCC
#7 #5 or #6
#8 MeSH descriptor: [Oropharynx] explode all trees
#9 oropharyn* or mesopharyn* or tonsil* or (head near/3 neck) or “tongue base”
#10 #8 or #9
#11 #7 and #10
#12 HNSCC or SCCHN or OP-SCC or OPSCC
#13 #1 or #2 or #3 or #4 or #11 or #12
#14 MeSH descriptor: [Deglutition] explode all trees
#15 MeSH descriptor: [Deglutition Disorders] this term only
#16 swallow* or deglutit* or dysphag*
#17 #14 or #15 or #16
#18 MeSH descriptor: [Exercise Therapy] explode all trees
#19 MeSH descriptor: [Isometric Contraction] explode all trees
#20 MeSH descriptor: [Behavior Therapy] explode all trees
#21 (swallow* or deglutit* or dysphag* or neuromuscular or mendelsohn or masako or “neuro muscular”) near/3 (exercis* or maneuver*
or manoeuvre* or manoeuver* or technique* or treatment* or strateg* or rehab* or therap*)
#22 isometric or IOPI or “iowa oral pressure instrument*” or pharyngocise
#23 nmt or “lingual exercis*” or “effortful swallow*” or “supraglottic swallow” or “super glottic swallow*” or “supra glottic swallow*”
#24 (tongue or BOT) near/3 (“range of motion” or ROM or resistance or strength* or holding)
#25 (voluntary near/3 (control or maneuver* or manoeuvre* or manoeuver*)) or “bearing down” or “progressive resistance” or “behav*
management” or (exercis* near/3 (therap* or regime)) or “therapeutic techniq*” or “behav* therap*” or “larygeal elevat*”
#26 #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25
#27 #26 and #17
#28 MeSH descriptor: [Deglutition Disorders] explode all trees and with qualifiers: [Prevention & control - PC, Rehabilitation - RH,
Therapy - TH]
#29 #27 or #28
#30 #13 and #29
C O N T R I B U T I O N S O F A U T H O R S
Alison Perry is the guarantor of the review. The protocol was written with contributions from Catriona Kennedy.
All authors (Perry, Kennedy and Cotton) will be involved in searching for trials, extracting data, interpreting the analyses and drafting
the final review. Specifically, Alison Perry and Sue Cotton will independently review the titles and abstracts of the records identified
from electronic searches and exclude immediately irrelevant studies. Alison Perry and Catriona Kennedy will select suitable studies
based on the inclusion criteria for the review. If these authors are unsure, Sue Cotton will make a final decision.
Alison Perry and Catriona Kennedy will independently extract study data and record information on a data extraction form, with Sue
Cotton acting as arbitrator.
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